Literature DB >> 27717267

Functional remediation: the pathway from remission to recovery in bipolar disorder.

Eduard Vieta1, Carla Torrent1.   

Abstract

Entities:  

Year:  2016        PMID： 27717267      PMCID： PMC5032507          DOI： 10.1002/wps.20351

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  9 in total

Review 1.  Cognition as a target in major depression: new developments.

Authors:  Brisa Solé; Esther Jiménez; Anabel Martinez-Aran; Eduard Vieta
Journal:  Eur Neuropsychopharmacol       Date:  2015-01-19       Impact factor: 4.600

2.  The NIMH experimental medicine initiative.

Authors:  Thomas R Insel
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

3.  Cognition as a target in schizophrenia, bipolar disorder and depression.

Authors:  Anabel Martinez-Aran; Eduard Vieta
Journal:  Eur Neuropsychopharmacol       Date:  2015-01-19       Impact factor: 4.600

4.  The bipolar maze: a roadmap through translational psychopathology.

Authors:  E Vieta
Journal:  Acta Psychiatr Scand       Date:  2014-03-18       Impact factor: 6.392

5.  Biomarkers and clinical staging in psychiatry.

Authors:  Patrick McGorry; Matcheri Keshavan; Sherilyn Goldstone; Paul Amminger; Kelly Allott; Michael Berk; Suzie Lavoie; Christos Pantelis; Alison Yung; Stephen Wood; Ian Hickie
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

6.  The influence of cognitive reserve on psychosocial and neuropsychological functioning in bipolar disorder.

Authors:  Irene Forcada; Maria Mur; Ester Mora; Eduard Vieta; David Bartrés-Faz; Maria J Portella
Journal:  Eur Neuropsychopharmacol       Date:  2014-08-15       Impact factor: 4.600

7.  Functional remediation in bipolar disorder: 1-year follow-up of neurocognitive and functional outcome.

Authors:  C M Bonnin; C Torrent; C Arango; B L Amann; B Solé; A González-Pinto; J M Crespo; R Tabarés-Seisdedos; M Reinares; J L Ayuso-Mateos; M P García-Portilla; Á Ibañez; M Salamero; E Vieta; A Martinez-Aran
Journal:  Br J Psychiatry       Date:  2015-11-05       Impact factor: 9.319

8.  Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study.

Authors:  Carla Torrent; Caterina del Mar Bonnin; Anabel Martínez-Arán; Jesús Valle; Benedikt L Amann; Ana González-Pinto; José Manuel Crespo; Ángela Ibáñez; Mari Paz Garcia-Portilla; Rafael Tabarés-Seisdedos; Celso Arango; Francesc Colom; Brisa Solé; Isabella Pacchiarotti; Adriane R Rosa; Jose Luis Ayuso-Mateos; Celia Anaya; Patricia Fernández; Ramon Landín-Romero; Silvia Alonso-Lana; Jordi Ortiz-Gil; Bàrbara Segura; Sara Barbeito; Patricia Vega; Miryam Fernández; Amaia Ugarte; Marta Subirà; Ester Cerrillo; Núria Custal; José Manuel Menchón; Jerónimo Saiz-Ruiz; Jose Maria Rodao; Sandra Isella; Analucía Alegría; Susana Al-Halabi; Julio Bobes; Gonzalo Galván; Pilar A Saiz; Vicent Balanzá-Martínez; Gabriel Selva; Inmaculada Fuentes-Durá; Patricia Correa; María Mayoral; Guadalupe Chiclana; Jessica Merchan-Naranjo; Marta Rapado-Castro; Manel Salamero; Eduard Vieta
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

9.  Functional remediation for bipolar disorder.

Authors:  Anabel Martínez-Arán; Carla Torrent; Brisa Solé; C Mar Bonnín; Adriane R Rosa; José Sánchez-Moreno; Eduard Vieta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2011-06-06
  9 in total
  7 in total

1.  Staging in bipolar disorder: from theoretical framework to clinical utility.

Authors:  Michael Berk; Robert Post; Aswin Ratheesh; Emma Gliddon; Ajeet Singh; Eduard Vieta; Andre F Carvalho; Melanie M Ashton; Lesley Berk; Susan M Cotton; Patrick D McGorry; Brisa S Fernandes; Lakshmi N Yatham; Seetal Dodd
Journal:  World Psychiatry       Date:  2017-10       Impact factor: 49.548

2.  The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management.

Authors:  Roger S McIntyre; Martin Alda; Ross J Baldessarini; Michael Bauer; Michael Berk; Christoph U Correll; Andrea Fagiolini; Kostas Fountoulakis; Mark A Frye; Heinz Grunze; Lars V Kessing; David J Miklowitz; Gordon Parker; Robert M Post; Alan C Swann; Trisha Suppes; Eduard Vieta; Allan Young; Mario Maj
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

3.  Predictors of Quality of Life Improvement with Escitalopram and Adjunctive Aripiprazole in Patients with Major Depressive Disorder: A CAN-BIND Study Report.

Authors:  Emma Morton; Venkat Bhat; Peter Giacobbe; Wendy Lou; Erin E Michalak; Shane McInerney; Trisha Chakrabarty; Benicio N Frey; Roumen V Milev; Daniel J Müller; Sagar V Parikh; Susan Rotzinger; Sidney H Kennedy; Raymond W Lam
Journal:  CNS Drugs       Date:  2021-04-16       Impact factor: 5.749

4.  Psychosocial Dysfunction in Major Depressive Disorder-Rationale, Design, and Characteristics of the Cognitive and Emotional Recovery Training Program for Depression (CERT-D).

Authors:  Matthew James Knight; Bernhard T Baune
Journal:  Front Psychiatry       Date:  2017-12-12       Impact factor: 4.157

5.  Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder.

Authors:  Caterina Del Mar Bonnín; María Reinares; Anabel Martínez-Arán; Esther Jiménez; Jose Sánchez-Moreno; Brisa Solé; Laura Montejo; Eduard Vieta
Journal:  Int J Neuropsychopharmacol       Date:  2019-08-01       Impact factor: 5.176

Review 6.  Potential Candidates for Biomarkers in Bipolar Disorder: A Proteomic Approach through Systems Biology.

Authors:  Paola Rampelotto Ziani; Jacson Gabriel Feiten; Jéferson Ferraz Goularte; Rafael Colombo; Bárbara Antqueviezc; Luiza Paul Géa; Adriane Ribeiro Rosa
Journal:  Clin Psychopharmacol Neurosci       Date:  2022-05-31       Impact factor: 3.731

Review 7.  Existing and emerging pharmacological approaches to the treatment of mania: A critical overview.

Authors:  Giulio Sparacino; Norma Verdolini; Eduard Vieta; Isabella Pacchiarotti
Journal:  Transl Psychiatry       Date:  2022-04-23       Impact factor: 7.989
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.